期刊文献+

肺表面活性物质新药及使用方法 被引量:1

下载PDF
导出
摘要 呼吸窘迫综合症(RDS)为肺表面活性物质(PS)缺乏所致,外源性PS对该病有特殊疗效。自1980年PS首次临床用后,许多国家竞相研制PS新药,迄今已研制出10多种PS新药。
作者 戚彩云 陈超
出处 《儿科药学》 1999年第4期2-3,共2页 Journal of Pediatric Pharmacy
  • 相关文献

参考文献5

二级参考文献9

共引文献37

同被引文献16

  • 1沈晓明,王卫平.儿科学[M].第7版,北京:人民卫生出版社,2010.136.
  • 2金汉珍,黄德珉,宫希吉.实用新生儿学[M].第3版.北京:人民卫生出版社,2004:143-147.
  • 3Avery ME,Mead J. Surface properties in relation to atelectasis andhyaline membrane disease [ J]. AMA J Dis Child, 1959,97(5):517-523.
  • 4Anaroff AA,Hack M,Walsh MC. The NICHD neonatal researchnetwork : changes in practiceand outomeduring the first 15 years[J]. Simin Perinato, 2003,27 (4) : 281.
  • 5Kamath BD,Macguire ER, McClure EM, et al. Neonatal mortalityfrom respiratory distress syndrome : lessons for -low-resourcecountries [ J]. Pediatrics, 2011, 127(6) : 1139-1146.
  • 6Lawn JE,Kerber K, Enweronu-Laryea C , et al. New born survivalin low resource settings : are we delivering [ J] ? BJOG, 2009 , 116(11) : 49-59.
  • 7Robertson PA, Sniderman SH, Laros RK Jr,et al. Neonatalmorbidity according to gestational age and birth weight from fivetertiary care centers in the United States, 1983 through 1986 [J].Am J Obstet Gynecol, 1992,166(6) : 1629-1641.
  • 8Angus DC, Liude-Zwirble WT,Clermont G, et al. Epidemiologyof neonatal respiratory failure in the United States : projections fromCalifornia and New York [ J]. Am J Respir Crit Care Med, 2001 ,164(7) : 1154-1160.
  • 9Narang A,Kumar P,Outta S,et al. Surfactant therapy forhyaline membrane disease : the Chandigarh experience [ J].Indian Pediatr, 2001,38(6) : 640-646.
  • 10St Clair C , Norwitz ER, Woensdregt K, et al. The probability ofneonatal respiratory distress syndrome as a function of gestationalage and lecithin/sphingomyelin ratio [ J]. Am J Perinatol,2008,25(8) : 473-480.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部